Neurodegenerative Diseases
Neurodegenerative Diseases - Related Videos
13:32
High Content Screening in Neurodegenerative Diseases
0 Views •
Cited by 8 •
2012
We describe a methodology combining automated cell culturing with high-content imaging to visualize and quantify multiple cellular processes and structures, in a high-throughput manner. Such methods can aid in the further functional annotation of genomes as well as identify disease gene networks and potential drug targets.
19:50
Interview: Protein Folding and Studies of Neurodegenerative Diseases
0 Views •
Cited by 2 •
2008
In this interview, Dr. Lindquist describes relationships between protein folding, prion diseases and neurodegenerative disorders. The problem of the protein folding is at the core of the modern biology. In addition to their traditional biochemical functions, proteins can mediate transfer of biological information and therefore can be considered a genetic material. This recently discovered function of proteins has important implications for studies of human disorders. Dr. Lindquist also...
04:37
Detecting Neurodegenerative Disease-Associated Protein α-Synuclein Using ELISA
0 Views •
2025
Source: Bétemps, D., et al., Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein. J. Vis. Exp. (2015).This video demonstrates the procedure to detect neurodegenerative disease-associated protein α-synuclein in brain tissue from transgenic mice using ELISA. The steps include tissue homogenization, centrifugation, and ELISA detection of α-synuclein protein to quantify its disease-associated forms.
09:33
Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
0 Views •
Cited by 49 •
2013
Diffusion tensor imaging (DTI) basically serves as an MRI-based tool to identify in vivo the microstructure of the brain and pathological processes due to neurological disorders within the cerebral white matter. DTI-based analyses allow for application to brain diseases both at the group level and in single subject data.
05:13
A Viral Vector Injection into the Rat Substantia Nigra for Neurodegenerative Disease Modeling
0 Views •
2025
This video demonstrates the process of injecting a viral vector into the rat substantia nigra to model Parkinson's disease. It outlines the steps for preparing the rat, microinjecting the viral vector into the substantia nigra, and the recovery procedure.
FAQs
Abnormal protein accumulation can disrupt neuronal function when proteins build up faster than cells can manage or remove them. Protein-clearance failure is therefore not simply a secondary feature; it may help sustain cellular stress and promote progressive neuronal injury. Studying these accumulations allows biologists to connect molecular waste-handling problems with later changes in nervous-system performance.
Neurons depend on effective mitochondrial activity and cellular transport to maintain their functions across long cellular extensions. When either process is disrupted, neurons may struggle to sustain normal activity or move essential materials within the cell. Examining these mechanisms helps researchers identify how intracellular failures contribute to neuronal vulnerability and where therapeutic targets might be developed.
Disease-related changes do not necessarily affect every neuron equally. Neurodegenerative processes can spread through neural circuits that contain particularly vulnerable cells, linking molecular damage with patterns of functional impairment. This circuit perspective helps explain why different disorders can produce distinct problems in movement, memory, cognition, or other nervous-system activities as degeneration advances.
Biologists combine genetic models, cell cultures, tissue analysis, and biomarker studies to examine neurodegeneration at different levels. Genetic models can support mechanistic investigation, cultured cells allow controlled study of cellular changes, and tissue analysis reveals effects in neural structures. Biomarker studies add measurable indicators that can connect biological processes with disease progression or diagnosis.
Biomarkers provide measurable biological information that researchers can use to investigate disease processes and support earlier diagnosis. In combination with genetic, cellular, or tissue-based evidence, they may help relate molecular changes to neuronal dysfunction. Their development is important because detecting disease-related changes earlier could improve the timing of therapeutic research and clinical decision-making.
These approaches are complementary rather than interchangeable. Genetic models help examine disease mechanisms in an organized biological system, cell cultures permit focused investigation of neuronal or cellular processes, and tissue analysis shows how changes appear in nervous-system structures. Using them together strengthens biological interpretation and supports the search for targets that could preserve neuronal function.